Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.

about

Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.

Item

http://www.wikidata.org/entity/Q52589536

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Mecasin treatment in patients ...... a randomized controlled trial.

@en

Mecasin treatment in patients ...... a randomized controlled trial.

@nl

type

Item

label

Mecasin treatment in patients ...... a randomized controlled trial.

@en

Mecasin treatment in patients ...... a randomized controlled trial.

@nl

prefLabel

Mecasin treatment in patients ...... a randomized controlled trial.

@en

Mecasin treatment in patients ...... a randomized controlled trial.

@nl

P1476

Mecasin treatment in patients ...... a randomized controlled trial.

@en

P2093

Bongkeun Song

http://www.w3.org/2001/XMLSchema#string

Dongwoung Kim

http://www.w3.org/2001/XMLSchema#string

Hyung Won Kang

http://www.w3.org/2001/XMLSchema#string

Ilhong Son

http://www.w3.org/2001/XMLSchema#string

Jae Kyoun Kim

http://www.w3.org/2001/XMLSchema#string

Jongdeok Lee

http://www.w3.org/2001/XMLSchema#string

Mi Ju Son

http://www.w3.org/2001/XMLSchema#string

Sungchul Kim

http://www.w3.org/2001/XMLSchema#string

Sungha Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis

Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery

Characteristics of pain in amyotrophic lateral sclerosis.

Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort.

Epidemiologic investigations of amyotrophic lateral sclerosis. 2. Familial aggregations indicative of dominant inheritance. I.

A study on the oral toxicity of mecasin in rats

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Rare diseases and orphan drugs.

A 4-week Repeated dose Oral Toxicity Study of Mecasin in Sprague-Dawley Rats to Determine the Appropriate Doses for a 13-week, Repeated Toxicity Test.

Incidence and prevalence of amyotrophic lateral sclerosis in Canada: a systematic review of the literature.

P2888

s13063-018-2557-z

P304

225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13063-018-2557-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103247202

http://www.w3.org/2001/XMLSchema#string

P698

29653550

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

5899359

http://www.w3.org/2001/XMLSchema#string